ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 137 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 8.14 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $372,000 | -49.0% | 19,800 | -69.3% | 0.00% | -50.0% |
| Q2 2019 | $730,000 | +69.0% | 64,600 | +166.9% | 0.00% | +33.3% |
| Q1 2019 | $432,000 | +112.8% | 24,200 | +22.2% | 0.00% | +200.0% |
| Q4 2018 | $203,000 | -53.0% | 19,800 | -18.2% | 0.00% | -66.7% |
| Q3 2018 | $432,000 | +10.5% | 24,200 | -2.4% | 0.00% | 0.0% |
| Q2 2018 | $391,000 | +30.3% | 24,800 | 0.0% | 0.00% | +50.0% |
| Q1 2018 | $300,000 | +28.2% | 24,800 | -2.0% | 0.00% | 0.0% |
| Q4 2017 | $234,000 | 0.0% | 25,300 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $234,000 | -23.0% | 25,300 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $304,000 | -43.0% | 25,300 | 0.0% | 0.00% | -60.0% |
| Q1 2017 | $533,000 | -7.3% | 25,300 | -8.0% | 0.01% | -16.7% |
| Q4 2016 | $575,000 | -27.7% | 27,500 | +8.3% | 0.01% | -33.3% |
| Q3 2016 | $795,000 | +28.6% | 25,400 | 0.0% | 0.01% | +28.6% |
| Q2 2016 | $618,000 | +40.8% | 25,400 | +35.1% | 0.01% | +40.0% |
| Q1 2016 | $439,000 | -41.6% | 18,800 | -14.9% | 0.01% | -44.4% |
| Q4 2015 | $752,000 | +5.8% | 22,100 | +1.8% | 0.01% | 0.0% |
| Q3 2015 | $711,000 | -27.1% | 21,700 | +17.9% | 0.01% | -25.0% |
| Q2 2015 | $975,000 | +89.7% | 18,400 | +3.4% | 0.01% | +100.0% |
| Q1 2015 | $514,000 | – | 17,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,203 | $36,042,000 | 9.93% |
| Foresite Capital Management II, LLC | 1,043,832 | $12,787,000 | 5.18% |
| Redmile Group, LLC | 6,476,766 | $79,340,000 | 3.91% |
| DAFNA Capital Management LLC | 346,013 | $4,239,000 | 2.63% |
| Cormorant Asset Management, LP | 900,000 | $11,025,000 | 1.95% |
| SENZAR ASSET MANAGEMENT, LLC | 641,170 | $7,854,000 | 1.92% |
| Asymmetry Capital Management, L.P. | 105,228 | $1,289,000 | 1.50% |
| New Leaf Venture Partners, L.L.C. | 171,364 | $2,099,000 | 0.97% |
| EMERALD ADVISERS, LLC | 1,578,477 | $19,336,000 | 0.79% |
| BB BIOTECH AG | 2,266,008 | $27,759,000 | 0.77% |